Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HiFIT: Iron and Tranexamic Acid in Hip Fracture
NCT02972294Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Mar 2017
- Primary completion
- Sep 2021
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ferric derisomaltose and tranexamic acid in anemia and hemorrhage, sponsored by Centre Hospitalier Universitaire d'Angers. Started Mar 2017; status: terminated.
02
Drugs
ferric derisomaltosetranexamic acid
03
Conditions
anemiahemorrhage
Beyond the preview
Go deeper on NCT02972294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02972294.